Author: Acteropharma
Simultaneously with the unveiling of Onkotaxel (Docetaxel of Actero Company), a subspecialized webinar was held on July 23rd with the presence of Dr. Safa Najafi (Medical Oncologist), Dr. Samiei (Radiotherapy Oncologist), Dr. Azimi Nejadan (Surgeon) and Ms. Dr. Ehsani (Pathologist) on August 2.
The webinar discussed the latest updates in breast cancer diagnosis and treatment, with 344 live broadcast participants and 203 replay viewers.
Author:
Author:
Author: